Oxford psilocybin depression study reaches final participant milestone
Summary
The final participant has completed their last visit in the COMP006 study at Oxford, marking the end of the active delivery phase at the NIHR Clinical Research Facility (CRF).
Description from Oxfordmail.
Who is covering this
-
Oxford psilocybin depression study reaches final participant milestone
The final participant has completed their last visit in the COMP006 study at Oxford, marking the end of the active delivery phase at the NIHR Clinical Research Facility (CRF).
Comments
Comments need JavaScript.